Inspire Medical Systems Inc.
INSP | NYSE
$75.72
-$1.06 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$75.70
-$0.02 (-0.03%)
After-hours:
Sep 21, 2026, 7:13 PM ET
Company Profile
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Key Executives
| Name | Position |
|---|---|
| Timothy Herbert | Founder, Chairman, Chief Executive Officer & President |
| Melissa J. Mann | Chief People Officer |
| Andreas Henke | Executive VP International & MD |
| Bryan K. Phillips | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
| Carlton W. Weatherby | Chief Strategy and Growth Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Ivan Lubogo | SVP of Strategic Sales |
| Jason Kelly | Chief Operations & Innovation Officer |
| John C. Rondoni | Chief Product & Innovation Officer |
| Joseph E. Sander | Senior Vice President of U.S. Sales |
| Matthew J. Osberg | Executive VP & CFO |
| Megan Rowekamp | Director of Financial Reporting |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 02, 2026 | 4 | Filing |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 11, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
| Aug 03, 2026 | 10-Q | Quarterly Report |
| Aug 03, 2026 | 8-K | Current Report |
| Jul 31, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 28, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 27, 2026 | 4 | Filing |
Inspire Medical Systems Inc.
| Country | United States |
| IPO Date | May 2, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 1,333 |
| CEO | Timothy Herbert |
Contact Details
5500 Wayzata Boulevard Golden Valley,
Minnesota 55416 United States
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| SIC Code | 3841 |
Recent News
- 3 days ago / gurufocus.comIs It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5.5% Rally? GF Value Says Undervalued
- 5 days ago / defenseworld.netHsbc Holdings PLC Has $274,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP
- 18 days ago / defenseworld.netBank of New York Mellon Corp Makes New $6.63 Million Investment in Inspire Medical Systems, Inc. $INSP
- 20 days ago / zacks.comWhy Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
- 27 days ago / globenewswire.comInspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
- 28 days ago / defenseworld.netBank of America Corp DE Trims Stock Holdings in Inspire Medical Systems, Inc. $INSP
- 1 month ago / zacks.comINSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
- 1 month ago / zacks.comHere's Why You Should Add INSP Stock to Your Portfolio Now
- 2 months ago / zacks.comIs INSP a Buy as Margins Improve but Reimbursement Risks Persist?
- 2 months ago / zacks.comINSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Add to Watchlist
Select watchlists to add or remove INSP